Lanolin: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 6: Line 6:
|drugClass=non-petroleum based lubricants
|drugClass=non-petroleum based lubricants
|indicationType=treatment
|indicationType=treatment
|indication=diaper [[dermatitis]] and protection of chafed skin or minor skin irritations due to incontinence  
|indication=diaper [[dermatitis]] and protection of chafed skin or minor skin irritations due to incontinence
|adverseReactions=<!--Black Box Warning-->
|adverseReactions=<!--Black Box Warning-->
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
Line 16: Line 16:


<!--FDA-Labeled Indications and Dosage (Adult)-->
<!--FDA-Labeled Indications and Dosage (Adult)-->
|fdaLIADAdult======Condition1=====
|fdaLIADAdult=There is limited information regarding <i>FDA-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


* Dosing Information
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


:* Dosage


=====Condition2=====
|offLabelAdultNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


* Dosing Information


:* Dosage


=====Condition3=====
* Dosing Information
:* Dosage
=====Condition4=====
* Dosing Information
:* Dosage
<!--Off-Label Use and Dosage (Adult)-->
<!--Guideline-Supported Use (Adult)-->
|offLabelAdultGuideSupport======Condition1=====
* Developed by:
* Class of Recommendation:
* Strength of Evidence:
* Dosing Information
:* Dosage
=====Condition2=====
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
<!--Non–Guideline-Supported Use (Adult)-->
|offLabelAdultNoGuideSupport======Condition1=====
* Dosing Information
:* Dosage
=====Condition2=====
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
<!--Pediatric Indications and Dosage-->
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed===Indications==
|fdaLIADPed===Indications==
* Helps prevent and treat diaper [[dermatitis]]
* Helps prevent and treat diaper [[dermatitis]]
Line 78: Line 30:
* Protects chafed skin or minor skin irritations due to incontinence and helps seal out wetness.
* Protects chafed skin or minor skin irritations due to incontinence and helps seal out wetness.
|offLabelPedGuideSupport=* There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedGuideSupport=* There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|warnings=* For External Use Only
|warnings=* For External Use Only
* Avoid contact with eyes
* Avoid contact with eyes
Line 92: Line 40:
* If swallowed, get medical help or contact a Poison Control Center right away
* If swallowed, get medical help or contact a Poison Control Center right away
|clinicalTrials=* There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|clinicalTrials=* There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=* There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=* There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|useInPregnancyAUS=* There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInPregnancyAUS=* There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
Line 122: Line 66:
<!--IV Compatibility-->
<!--IV Compatibility-->
|IVCompat=* There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|IVCompat=* There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|overdose=* There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
|overdose=* There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.


Line 155: Line 97:
[[File:Lanolin ingredients and appearance.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
[[File:Lanolin ingredients and appearance.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
|brandNames=*  LANOLIN ®<ref>{{Cite web | title =lanolin ointment| url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87216888-1753-4fd5-a8e0-d8347948b082 }}</ref>
|brandNames=*  LANOLIN ®<ref>{{Cite web | title =lanolin ointment| url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87216888-1753-4fd5-a8e0-d8347948b082 }}</ref>
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>


Revision as of 17:16, 22 April 2015

Lanolin
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Lanolin is a non-petroleum based lubricants that is FDA approved for the treatment of diaper dermatitis and protection of chafed skin or minor skin irritations due to incontinence. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding FDA-Label Guideline-Supported Use of Lanolin in adult patients.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Lanolin in adult patients.

Non–Guideline-Supported Use

  • There is limited information regarding Off-Label Non–Guideline-Supported Use of Lanolin in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indications

  • Protects chafed skin or minor skin irritations due to incontinence and helps seal out wetness.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

  • There is limited information regarding Off-Label Guideline-Supported Use of Lanolin in pediatric patients.

Non–Guideline-Supported Use

  • There is limited information regarding Off-Label Non–Guideline-Supported Use of Lanolin in pediatric patients.

Contraindications

There is limited information regarding Lanolin Contraindications in the drug label.

Warnings

  • For External Use Only
  • Avoid contact with eyes
  • Do not apply to deep or puncture wounds
  • If condition worsens, or does not improve within 7 days, consult a doctor

KEEP OUT OF REACH OF CHILDREN

  • If swallowed, get medical help or contact a Poison Control Center right away

Adverse Reactions

Clinical Trials Experience

  • There is limited information regarding Clinical Trial Experience of Lanolin in the drug label.

Postmarketing Experience

  • There is limited information regarding Postmarketing Experience of Lanolin in the drug label.

Drug Interactions

There is limited information regarding Lanolin Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Lanolin in women who are pregnant.
Pregnancy Category (AUS):

  • There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Lanolin in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Lanolin during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Lanolin with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Lanolin with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Lanolin with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Lanolin with respect to specific gender populations.

Race

There is no FDA guidance on the use of Lanolin with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Lanolin in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Lanolin in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Lanolin in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Lanolin in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Topical
  • Gently cleanse and dry area
  • Apply liberally to affected area as needed
  • Avoid contact with eyes
  • Do not apply to deep or puncture wounds
  • If condition worsens, or does not improve within 7 days, consult a doctor

Monitoring

  • There is limited information regarding Monitoring of Lanolin in the drug label.

IV Compatibility

  • There is limited information regarding IV Compatibility of Lanolin in the drug label.

Overdosage

  • There is limited information regarding Chronic Overdose of Lanolin in the drug label.

Pharmacology

There is limited information regarding Lanolin Pharmacology in the drug label.

Mechanism of Action

Structure

File:Lanolin01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Lanolin in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Lanolin in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Lanolin in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Lanolin in the drug label.

How Supplied

Storage

There is limited information regarding Lanolin Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Lanolin |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

This image is provided by the National Library of Medicine.
This image is provided by the National Library of Medicine.

{{#ask: Label Page::Lanolin |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Lanolin in the drug label.

Precautions with Alcohol

  • Alcohol-Lanolin interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "lanolin ointment".
  2. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Page Name=Lanolin
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Lanolin
 |Label Name=Lanolin11.png

}}

{{#subobject: 

 |Label Page=Lanolin
 |Label Name=Lanolin11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Lanolin&oldid=1090494"